Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Male pattern baldness may predict prostate cancer risk.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Post-finasteride syndrome's existence is uncertain; more research needed.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.